While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

General Mills said the new cost-control push will yield $100 million or more in savings on top of $600 million in gross ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Q: My very experienced cardiologist noted recently that for many patients, including me, losing weight improves many heart health issues. It really doesn’t matter how the weight loss happens, as long ...

Allurion Technologies (ALUR) announced initial results on the combination of the Allurion Program with low-dose GLP-1 therapy to optimize ...

Chilean foodtech firm NotCo says it expects to be profitable in Chile, Argentina, Colombia, and Peru in Q2, 2025.

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

Hollywood has in recent years been undergoing a much-needed, long-awaited transformation in its portrayals of women and ...

GLP-1 medications are making headlines in medical weight loss—learn how they impact overall health and chronic disease ...